DK1238065T3 - Faktor X-analog med forbedret evne til aktivering - Google Patents
Faktor X-analog med forbedret evne til aktiveringInfo
- Publication number
- DK1238065T3 DK1238065T3 DK00949465T DK00949465T DK1238065T3 DK 1238065 T3 DK1238065 T3 DK 1238065T3 DK 00949465 T DK00949465 T DK 00949465T DK 00949465 T DK00949465 T DK 00949465T DK 1238065 T3 DK1238065 T3 DK 1238065T3
- Authority
- DK
- Denmark
- Prior art keywords
- analog
- factor
- enhanced activation
- activation capability
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0137799A AT410216B (de) | 1999-08-10 | 1999-08-10 | Faktor x-analogon mit verbesserter aktivierbarkeit |
PCT/EP2000/007631 WO2001010896A2 (en) | 1999-08-10 | 2000-08-07 | Factor x analog with an improved ability to be activated |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1238065T3 true DK1238065T3 (da) | 2008-07-07 |
Family
ID=3512576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00949465T DK1238065T3 (da) | 1999-08-10 | 2000-08-07 | Faktor X-analog med forbedret evne til aktivering |
Country Status (9)
Country | Link |
---|---|
US (1) | US6958322B1 (da) |
EP (1) | EP1238065B1 (da) |
AT (2) | AT410216B (da) |
AU (1) | AU778571B2 (da) |
CA (1) | CA2380844A1 (da) |
DE (1) | DE60038312T2 (da) |
DK (1) | DK1238065T3 (da) |
ES (1) | ES2302696T3 (da) |
WO (1) | WO2001010896A2 (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040480A1 (en) * | 2001-07-20 | 2003-02-27 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
CA2592521A1 (en) * | 2004-08-17 | 2006-02-23 | Csl Behring Gmbh | Modified vitamin k dependent polypeptides |
EP1728798A1 (en) * | 2005-06-01 | 2006-12-06 | ZLB Behring GmbH | Coagulation factor X polypeptides with modified activation properties |
MX336958B (es) * | 2005-11-15 | 2016-02-05 | Philadelphia Children Hospital | Metodos y composiciones para modular la hemostasia. |
EP1820508A1 (en) * | 2006-02-21 | 2007-08-22 | CSL Behring GmbH | Coagulation factor X polypeptides with modified activation properties |
AU2008253230B2 (en) | 2007-05-22 | 2013-07-18 | Takeda Pharmaceutical Company Limited | Preparative purification process for human furin |
WO2009088876A2 (en) | 2007-12-31 | 2009-07-16 | Baxter International Inc. | Transgenic non-human animals expressing human blood clotting factors and uses thereof |
AU2010279463A1 (en) | 2009-08-04 | 2012-03-01 | Baxter Healthcare S.A. | Transgenic mouse knockout for FVIII and VWF - model of hemophilia A |
WO2013049804A1 (en) | 2011-09-30 | 2013-04-04 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating hemostasis |
WO2014018120A1 (en) | 2012-07-25 | 2014-01-30 | Catalyst Biosciences, Inc. | Modified factor x polypeptides and uses thereof |
US20150343034A1 (en) | 2013-01-31 | 2015-12-03 | Pfizer Inc. | Compositions and methods for counteracting factor xa inhibition |
FR3001729B1 (fr) * | 2013-02-04 | 2015-03-06 | Lab Francais Du Fractionnement | Mutants du facteur x |
MY173548A (en) | 2013-09-24 | 2020-02-04 | Pfizer | Fxa variant compositions |
US10676731B2 (en) | 2014-08-19 | 2020-06-09 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating factor IX function |
FR3050992A1 (fr) * | 2016-05-06 | 2017-11-10 | Lab Francais Du Fractionnement | Mutants du facteur x |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT366916B (de) | 1980-04-02 | 1982-05-25 | Immuno Ag | Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen |
US4501731A (en) | 1983-06-27 | 1985-02-26 | Tishkoff Garson H | Treatment of disparate bleeding disorders with factor X zymogen |
AT382783B (de) | 1985-06-20 | 1987-04-10 | Immuno Ag | Vorrichtung zur applikation eines gewebeklebstoffes |
US5597799A (en) | 1990-09-04 | 1997-01-28 | Cor Therapeutics, Inc. | Recombinant agents affecting thrombosis |
ES2109336T3 (es) | 1990-11-26 | 1998-01-16 | Genetics Inst | Expresion de pace en celulas huesped y metodos de utilizacion de la misma. |
US5621039A (en) | 1993-06-08 | 1997-04-15 | Hallahan; Terrence W. | Factor IX- polymeric conjugates |
DE4325872C1 (de) | 1993-08-02 | 1994-08-04 | Immuno Ag | Virusinaktivierte Faktor Xa-Präparation |
AT401270B (de) | 1994-09-26 | 1996-07-25 | Immuno Ag | Verfahren zur quantifizierung von genomischer dna |
AT404838B (de) | 1995-11-24 | 1999-03-25 | Immuno Ag | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen |
AT405516B (de) * | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-analoge mit modifizierter proteasespaltstelle |
AT405517B (de) | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-deletionsmutanten und analoge davon |
-
1999
- 1999-08-10 AT AT0137799A patent/AT410216B/de not_active IP Right Cessation
-
2000
- 2000-08-04 US US09/632,722 patent/US6958322B1/en not_active Expired - Lifetime
- 2000-08-07 AT AT00949465T patent/ATE389013T1/de active
- 2000-08-07 DK DK00949465T patent/DK1238065T3/da active
- 2000-08-07 WO PCT/EP2000/007631 patent/WO2001010896A2/en active IP Right Grant
- 2000-08-07 ES ES00949465T patent/ES2302696T3/es not_active Expired - Lifetime
- 2000-08-07 AU AU62807/00A patent/AU778571B2/en not_active Ceased
- 2000-08-07 EP EP00949465A patent/EP1238065B1/en not_active Expired - Lifetime
- 2000-08-07 CA CA002380844A patent/CA2380844A1/en not_active Abandoned
- 2000-08-07 DE DE60038312T patent/DE60038312T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2001010896A2 (en) | 2001-02-15 |
US6958322B1 (en) | 2005-10-25 |
CA2380844A1 (en) | 2001-02-15 |
ES2302696T3 (es) | 2008-08-01 |
AT410216B (de) | 2003-03-25 |
DE60038312D1 (de) | 2008-04-24 |
EP1238065A2 (en) | 2002-09-11 |
ATE389013T1 (de) | 2008-03-15 |
ATA137799A (de) | 2002-07-15 |
EP1238065B1 (en) | 2008-03-12 |
AU6280700A (en) | 2001-03-05 |
AU778571B2 (en) | 2004-12-09 |
WO2001010896A3 (en) | 2002-07-11 |
DE60038312T2 (de) | 2009-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1238065T3 (da) | Faktor X-analog med forbedret evne til aktivering | |
HUP0300586A2 (hu) | Módosított VIII-as faktor | |
DE69811612D1 (de) | Verfahren zur Herstellung von Reinst-Epichlorhydrin | |
ATE308550T1 (de) | Verwendungen von sulfatierten fuko- oligosacchariden zum pflanzenschutz | |
DE60108042D1 (de) | Prozesse zur Herstellung von pulverförmigen Schlagzäh-Modifizierern | |
DE69835357D1 (de) | Verfahren zur Herstellung von Synthesegas | |
DE69920642D1 (de) | Photokatalysator enthaltend organisch-inorganisch hybrid Zusammensetzungen, und dessen Herstellungsverfahren | |
FI980862A (fi) | Kiraalisia metyylifenyylioksatsolidinoneja | |
DE69938535D1 (de) | Dampfphasenprozess zur Herstellung von Aluminid | |
HUP0001138A3 (en) | Amino acids containing benzodioxane or benzoxazine, pharmaceutical compositions thereof and process for producing the same | |
MY129372A (en) | Process to prepare oxazolidinones | |
DE69901569D1 (de) | Humane antikörper gegen faktor ix/ixa | |
DE69904090D1 (de) | Verfahren zur industriellen Herstellung von hochreinem Wasserstoffperoxid | |
GB0216001D0 (en) | Process and composition | |
DE59709869D1 (de) | Neue substanzbibliothek und damit hergestellte supramolekulare komplexe | |
HUP0202729A2 (hu) | Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények | |
DE59902109D1 (de) | Gaskarburierungsverfahren zur Herstellung von reinem WC-Pulver | |
DE69808475D1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
MXPA02004829A (es) | Metodo para la sintesis estereoselectiva de aminoacidos ciclicos. | |
DE19983485T1 (de) | Verfahren zur Herstellung von Gasfedern | |
DE69812438T2 (de) | Zusammensetzung zur herstellung von brennstoff-briketts | |
ATE242763T1 (de) | Methoximinophenylessigsäureamide | |
PT1246790E (pt) | Bases de mannich de 1- e 2-naftol substituido | |
ATE331733T1 (de) | Metallhaltige ribonukleotidpolypeptide | |
IL162919A0 (en) | Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxo-propoxy)-11.bedroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.b |